fda drug safety communication semaglutide naion 2025 The sent a warning letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know You've seen the headlines. Should

If you have been diagnosed with diabetic retinopathy, follow your eye physicians recommendations on how closely you should be monitored

I stood there doing the math in my head, realizing my bodys next chapter wasnt up to me anymore

Lebers hereditary optic neuropathy, a rare genetic disorder affecting the optic nerve, has been associated with rapid optic atrophy following cyanocobalamin administration in some cases

Maryland Trim Clinic (MTC) in Laurel, MD For patients exploring medically supervised weight management options, Maryland Trim Clinic in Laurel, MD offers support focused on personalized metabolic and wellness care

Cell Metab (2018) 27(4):74056

Semaglutide is a GLP-1 receptor agonist originally developed for blood sugar regulation in type 2 diabetes